Edward Morello

I would be grateful, Madam Deputy Speaker, if you could pass on my thanks to Mr Speaker for granting this urgent question. I thank the Minister for his response. The collapse of service provision in some places, the constant closures in others and the general governance at Jhoots pharmacy, which operates 150 branches across England, demands immediate ministerial intervention. In West Dorset, Jhoots branches in Lyme Regis and Bridport have been closed for months, leaving thousands without access to essential medication and placing a huge strain on overstretched neighbouring pharmacies. Jhoots staff have gone months without pay, despite payslips being issued, tax deductions made and pension contributions not deposited. I have been contacted only this morning by staff who have not been paid for the third month. Many are unable to buy food or pay rent. They are relying on food banks and the amazing communities that have stepped up to support them. There have been reports of staff recruited by Jhoots under skilled worker visas being left without income or resource. I have also been made aware of deeply troubling reports of controlled drugs being removed without proper documentation or process, which if proven true may constitute a breach of the Misuse of Drugs Act 1971. I have raised my concerns with the General Pharmaceutical Council, His Majesty’s Revenue and Customs, the NHS Business Services Authority, the ICB and the Minister, whom I thank for his response. I understand that processes must be followed, but this situation requires immediate action. Jhoots staff are not being paid and people across the country do not have access to vital medicine. Will the Minister please confirm what steps are being taken to ensure that all Jhoots staff are paid without delay? What discussions have taken place with the NHS BSA, the General Pharmaceutical Council and other regulators about Jhoots’s business practices? Finally, will the Government commit to urgently reviewing Jhoots’s suitability as an NHS pharmacy provider, outline what safeguards will be introduced to prevent this from happening again and review the pharmacy funding model?